Back

Design of the EMPERIAL-reduced trial of empagliflozin in patients with chronic heart failure with reduced ejection fraction

28 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor William Abraham

The Ohio State University, Columbus (United States of America)

43 More presentations in this session

Presentation thumbnail
Doctor P. Pellicori (Glasgow, GB)
Abstract
Presentation thumbnail
Miss M. Diz (Sao Paulo, BR)
Abstract
Presentation thumbnail
Professor R. Bestetti (Ribeirao Preto, BR)
Abstract Slides
Presentation thumbnail
Doctor S. Cazalbou (Toulouse, FR)
Abstract
Presentation thumbnail
Miss A. Zaplatina (Saint Petersburg, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

28 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources